Stockhub

9 Meters Biopharma, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 August 2022

11 August 2022

30 July 2022

  • curprev 13:2213:22, 30 July 2022‎ Chris talk contribs‎ 963 bytes +963‎ Created page with "9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide, a long-acting injectabl..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/9_Meters_Biopharma,_Inc.’